Pathogenic ␣-synuclein (␣S) gene mutations occur in rare familial Parkinson's disease (PD) kindreds, and wild-type ␣S is a major component of Lewy bodies (LBs) in sporadic PD, dementia with LBs (DLB), and the LB variant of Alzheimer's disease, but -synuclein (S) and ␥-synuclein (␥S) have not yet been implicated in neurological disorders. Here we show that in PD and DLB, but not normal brains, antibodies to ␣S and S reveal novel presynaptic axon terminal pathology in the hippocampal dentate, hilar, and CA2͞3 regions, whereas antibodies to ␥S detect previously unrecognized axonal spheroid-like lesions in the hippocampal dentate molecular layer. The aggregation of other synaptic proteins and synaptic vesicle-like structures in the ␣S-and S-labeled hilar dystrophic neurites suggests that synaptic dysfunction may result from these lesions. Our findings broaden the concept of neurodegenerative ''synucleinopathies'' by implicating S and ␥S, in addition to ␣S, in the onset͞progression of PD and DLB.perforant pathway ͉ mossy fibers T he synucleins are a family of soluble presynaptic proteins that are abundant in neurons and include ␣-synuclein (␣S) (also known as the nonamyloid component of plaques precursor protein or NACP) (1, 2), -synuclein (S) (also known as phosphoneuroprotein 14 or PNP14) (3, 4), and ␥-synuclein (␥S) (also known as breast cancer-specific gene 1 or BCSG1 and persyn) (5, 6). Although they are homologous, each synuclein is encoded by a different gene on chromosomes 4q21.3-q22 (␣S) (7, 8), 5q35 (S) (9), and 10q23 (␥S) (10).The functions of synucleins are poorly understood; however, mutations in the ␣S gene are linked to familial Parkinson's disease (PD) in rare kindreds (11,12). ␣S is a major component of Lewy bodies (LBs) and Lewy neurites in sporadic PD, dementia with LBs (DLB) and a subtype of Alzheimer's disease (AD) with abundant neocortical LBs known as the LB variant of AD (13-15). Further, LBs have been described in familial AD caused by presenilin and amyloid precursor protein gene mutations (16) and Down's syndrome (17). In addition, ␣S is a major component of glial cytoplasmic inclusions (GCIs) in multiple system atrophy (MSA) (18, 19) as well as the neuronal inclusions and GCIs in Hallervorden-Spatz disease (18). Heretofore, S and ␥S have not been implicated in neurodegenerative disease (15, 18), although ␥S may play a role in breast cancer progression (5).Here, we report the identification of axonal pathology with antibodies to S and ␥S in the hippocampus of PD and DLB brains, but not in control brains, thereby implicating S and ␥S, in addition to ␣S, in neurodegenerative disease.
MethodsCase Materials. Brains of autopsy proven PD (n ϭ 5), DLB (n ϭ 5), AD (n ϭ 5), MSA (n ϭ 2), Pick's disease (n ϭ 2), and normal controls (n ϭ 5) were examined and compared after postmortem assessment in the Center for Neurodegenerative Disease Research at the University of Pennsylvania School of Medicine to establish a neuropathological diagnosis in each case (15-18, 20).Immunohistochemistry. Immu...